稠合嘧啶

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

MATTHIAS VENNEMANN M,THOMAS BAER T,THOMAS MAIER T,SWEN HOELDER S,GERRIT BENEKE G,FLORIAN DEHMEL F,ARMIN ZUELCH A,ANDREAS STRUB A,THOMAS BECKERS T,STUART INCE S,HARTMUT REHWINKEL H,NINGSHU LIU,ULF BOEM,.芬內曼,.貝爾,.邁爾,.赫爾德,.貝內克,.德默爾,.齊爾希,.施特魯布,.貝克爾斯,STUART IN

申请号：

HK12106259.9

公开号：

HK1165423B

申请日:

2012.06.27

申请国别(地区):

HK

年份:

2015

代理人:

摘要：

Compounds of formula (I) or an N-oxide, a salt, a tautomer or a stereoisomer of said compound, or a salt of said N-oxide, tautomer or stereoisomer, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6, R7, m and n have the meanings as given in the description and the claims, which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/